Low procedure-related mortality achieved with alcohol septal ablation in European patients

Abstract

Two thirds of patients with hypertrophic cardiomyopathy (HCM) suffer from a left ventricular obstruction associated with more symptoms and worse prognosis. According to American and European Guidelines on HCM, there are two main therapeutic alternatives for treating the left ventricular obstruction: surgical myectomy and alcohol septal ablation (ASA).

Both these alternatives are considered safe and effective.

Keywords

• hypertrophic cardiomyopathy
• task-force
• guidelines
• diagnosis
• myectomy